Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: A phase 2 trial

By Abou-Jawde Rony   Reed Janice   Kelly Megan   Walker Esteban   Andresen Steven   Baz Rachid   Karam Mary   Hussein Mohamad  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 263-272

Humana Press, Inc

Access to resources Recommend Favorite

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

By Held Lauren A.   Rizzieri David   Long Gwynn D.   Gockerman Jon P.   Diehl Louis F.   Castro Carlos M. de   Moore Joseph O.   Horwitz Mitchell E.   Chao Nelson J.   Gasparetto Cristina  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 172-176

Informa Healthcare

Access to resources Recommend Favorite

Coagulation in Hematological Malignancies

By Falanga Anna   Vignoli Alfonso   Marchetti Marina  

Cancer Investigation, Vol. 27, Iss. 1, 2009-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: A clinical experience

By Subbarayan Pochi R.   Lima Mayra   Ardalan Bach  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 557-561

Informa Healthcare

Access to resources Recommend Favorite

Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia

By Au Wing-yan   Lang Brian H.   Fong Bonnie M. W.   Mao Kevin J.   Tam Sidney  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1184-1185

Informa Healthcare

Access to resources Recommend Favorite